1. Home
  2. UGI vs RGEN Comparison

UGI vs RGEN Comparison

Compare UGI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UGI Corporation

UGI

UGI Corporation

HOLD

Current Price

$38.11

Market Cap

8.1B

Sector

Utilities

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$166.20

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UGI
RGEN
Founded
1940
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UGI
RGEN
Price
$38.11
$166.20
Analyst Decision
Buy
Buy
Analyst Count
1
10
Target Price
$44.00
$174.90
AVG Volume (30 Days)
2.1M
630.5K
Earning Date
02-04-2026
10-28-2025
Dividend Yield
3.90%
N/A
EPS Growth
147.20
N/A
EPS
3.09
0.03
Revenue
$7,287,000,000.00
$707,890,000.00
Revenue This Year
$21.37
$17.84
Revenue Next Year
$3.03
$12.44
P/E Ratio
$12.44
$6,528.73
Revenue Growth
1.07
11.74
52 Week Low
$27.53
$102.97
52 Week High
$39.59
$182.52

Technical Indicators

Market Signals
Indicator
UGI
RGEN
Relative Strength Index (RSI) 57.43 57.69
Support Level $37.89 $156.01
Resistance Level $38.70 $167.74
Average True Range (ATR) 0.60 4.27
MACD -0.13 0.04
Stochastic Oscillator 64.02 81.59

Price Performance

Historical Comparison
UGI
RGEN

About UGI UGI Corporation

UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: